A hidden strategy: How SARS-CoV-2 uses fibrinogen to evade the immune system
As scientists, we often think we understand a virus—its structure, its tricks, the way it moves through the body. But every ...
Pulmonology Advisor10h
COVID And The Eye: What We’ve Learned 5 Years Since The Start of The Pandemic
Five years from the start of the COVID-19 pandemic, numerous academic studies have shown how the novel coronavirus affects ocular health.
SARS-CoV-2 Virus Is Still Circulating! Experts Warn – Here’s How To Boost Your Immunity To Stay Safe
Covid-19 is still circulating, though it's weaker now. Experts say it’s not a major threat but advise maintaining strong ...
AI learns to 'speak' genetic 'dialect' for future SARS-CoV-2 mutation prediction
It's been five years since COVID-19 was declared a global pandemic. As SARS-CoV-2 shifts to endemic status, questions about ...
Medscape1d
No Rise in T2D Risk After Mild COVID-19 in Vaccinated Adults
No increased risk for new-onset T2D was found after mild SARS-CoV-2 infection in a multiethnic Asian cohort during the ...
What to know about the new Covid strain affecting three in five UK patients
The latest variant on the rise is LP.8.1. It’s increasing in Australia, making up close to one in five COVID cases in New ...
Researchers develop nasal spray H5N1 avian influenza vaccine
The State Key Laboratory for Emerging Infectious Diseases at the University of Hong Kong (HKU) and the InnoHK Center for ...
Scientific American7d
COVID Research Funding to Be Slashed, NIH Documents Show
Studies on COVID, climate change and South Africa are on the latest list of terminated grants by the U.S. National Institutes ...
Queens Chronicle1d
First they called it ‘the novel coronavirus’
The first mention of Covid-19 in the Queens Chronicle came on Jan. 30, 2020, in a story headlined “Coronavirus fears seep ...
Physician's Weekly14h
Molnupiravir Impact on Viral Clearance and Treatment Duration
The following is a summary of “A viro-immunological model to characterize the antiviral effect of molnupiravir in SARS-CoV-2-infected outpatients: implication for treatment duration,” published in the ...